SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals reports 11.70% rise in Q2 consolidated net profit

19 Oct 2012 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2012.

On standalone basis, the company has posted a rise of 9.13% in its net profit at Rs 41.47 crore for the quarter ended September 30, 2012 as compared to Rs 38.00 crore for the same quarter in the previous year. Total income has increased by 5.64% at Rs 406.85 crore for quarter under review as compared to Rs 385.12 crore for the quarter ended September 30, 2011.

On consolidated basis, the company has posted a rise  of 11.70% in its net profit at Rs 42.49 crore for the quarter ended September 30, 2012 as compared to Rs 38.04 crore for the same quarter in the previous year.  Total income has increased by 2.23% at Rs 406.85 crore for quarter under review as compared to Rs 397.99 crore for the quarter ended September 30, 2011.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

759.00 -25.95 (-3.31%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×